Pharmena Ratios and Metrics

Market cap in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	38	29	43	79	62	88
Market Cap Growth	-23.78%	-32.12%	-46.06%	26.79%	-29.20%	-10.89%
Enterprise Value	31	29	32	57	72	96
Last Close Price	3.43	2.60	3.83	6.41	5.05	7.14
PE Ratio	-	-	-	2.73	-	-
PS Ratio	24.22	18.36	159.17	264.48	208.60	5.79
PB Ratio	3.96	3.00	3.44	3.56	-9.18	-17.20
P/TBV Ratio	4.58	3.47	3.78	3.53	-	-
P/FCF Ratio	-	-	-	2.42	39.15	-
P/OCF Ratio	-	-	-	2.39	34.29	-
EV/Sales Ratio	19.56	18.25	119.44	191.28	241.50	6.34
EV/EBITDA Ratio	-	-	-	1.74	-	-
EV/EBIT Ratio	-	-	-	1.74	-	-
EV/FCF Ratio	-8.74	-	-	1.75	45.33	-
Debt / Equity Ratio	0.04	0.04	0.02	0.01	-1.49	-1.90
Debt / EBITDA Ratio	-	-	-	0.01	-	-
Debt / FCF Ratio	-	-	-	0.01	6.37	-
Net Debt / Equity Ratio	-0.76	-0.76	-0.12	-0.99	-1.26	-1.61
Net Debt / EBITDA Ratio	2.26	2.26	0.44	-0.67	-2.16	-2.14
Net Debt / FCF Ratio	2.09	2.09	0.55	-0.67	5.37	-2.33
Asset Turnover	0.13	0.13	0.01	0.02	0.03	1.38
Inventory Turnover	0.38	0.38	0.12	0.12	0.05	1.82
Quick Ratio	8.35	8.35	2.22	12.84	0.30	0.40
Current Ratio	9.20	9.20	12.98	13.17	0.59	0.71
Return on Equity (ROE)	-25.09%	-25.09%	-7.29%	350.10%	-	-
Return on Assets (ROA)	-16.77%	-16.77%	-11.30%	111.71%	-21.39%	-22.93%
Return on Invested Capital (ROIC)	-51.84%	-49.69%	-61.37%	2788.37%	-166.20%	-123.45%
Return on Capital Employed (ROCE)	-33.00%	-33.00%	-27.00%	146.70%	92.50%	949.40%
Earnings Yield	-7.25%	-9.56%	-2.96%	36.60%	-2.52%	-5.21%
FCF Yield	-9.23%	-12.18%	-6.35%	41.37%	2.55%	-4.02%
Dividend Yield	24.78%	-	22.19%	13.27%	-	-
Buyback Yield / Dilution	-	-	-	-	-0.25%	-1.25%
Total Shareholder Return	24.71%	-	22.19%	13.27%	-0.25%	-1.25%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.